HYE GYEONG JEONG

Dr. HYE GYEONG JEONG

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
HJHYE GYEONG JEONG
HYE GYEONG JEONG
HPHyuntae Park
Hyuntae Park
Menopause is an aging process and an important time equivalent to one-third of a woman’s lifetime. Menopause significantly increases the risk of cardiometabolic diseases, such as obesity, type 2 diabetes, cardiovascular diseases, non-alcoholic liver disease (NAFLD)/metabolic associated fatty liver disease (MFFLD), and metabolic syndrome (MetS). Women experience a variety of symptoms in the perimenopausal period, and these symptoms are distressing for most women. Many factors worsen a woman’s menopausal experience, and controlling these factors may be a strategy to improve postmenopausal women’s health. This review aimed to confirm the association between menopause and metabolic diseases (especially MetS), including pathophysiology, definition, prevalence, diagnosis, management, and prevention.

1 September 2021 in Clinical and Experimental Reproductive Medicine
Verified
Journal Article
Open access
PDF file
BJByung Chul Jee
Byung Chul Jee
HJHYE GYEONG JEONG
HYE GYEONG JEONG
Considerable disagreement exists regarding whether endometrial polyps should be removed before attempting natural pregnancy and before pregnancy via intrauterine insemination (IUI) or in vitro fertilization (IVF). Through a literature review, we obtained information on the impact of endometrial polyps and polypectomy on fertility outcomes. Several observational studies have suggested that women with unexplained infertility may benefit from endometrial polypectomy for a future natural pregnancy. A few studies reported benefits from endometrial polypectomy in infertile women who plan to undergo IUI. However, no strong evidence supports polypectomy as a way to improve the pregnancy rate in infertile women who plan to undergo IVF or polypectomy during controlled ovarian stimulation for IVF. Although no studies have defined criteria for the polyp size that should be removed in infertile women, clinicians should be aware that small endometrial polyps (<10 mm) sometimes regress spontaneously. Endometrial polypectomy is currently justified in patients with repeated IVF failure, but more studies are needed to verify that endometrial polypectomy itself will eventually increase the pregnancy rate. Although several mechanisms by which endometrial polyps exert a negative effect on fertility have emerged, there is no consensus about the proper management of endometrial polyps in infertile women. Therefore, the management of endometrial polyps should be individualized depending on the patient's situation and clinician’s preference.

1 January 2018 in Obstetrics & Gynecology Science
Verified
Journal Article
Open access
PDF file
MKMin Kyoung Kim
Min Kyoung Kim
SLSeung Mi Lee
Seung Mi Lee
JOJung Won Oh
Jung Won Oh
SKSo Yeon Kim
So Yeon Kim
HJHYE GYEONG JEONG
HYE GYEONG JEONG
JPJoong Shin Park
Joong Shin Park
Kim MK, et al. Obstet Gynecol Sci. 2018 Jan;61(1):63-70. https://doi.org/10.5468/ogs.2018.61.1.63

9 November 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
KRKi-Jin Ryu
Ki-Jin Ryu
HPHyuntae Park
Hyuntae Park
YJYujin Jeong
Yujin Jeong
SNSeunghyun Nam
Seunghyun Nam
HJHYE GYEONG JEONG
HYE GYEONG JEONG
TKTak Kim
Tak Kim
Ryu KJ, et al. J Korean Med Sci. 2022 Nov;37(45):e330. https://doi.org/10.3346/jkms.2022.37.e330

1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
KRKi-Jin Ryu
Ki-Jin Ryu
WWWon Young Wi
Won Young Wi
SNSeunghyun Nam
Seunghyun Nam
HJHYE GYEONG JEONG
HYE GYEONG JEONG
GCGeum Joon Cho
Geum Joon Cho
TKTak Kim
Tak Kim
Ryu KJ, et al. J Korean Med Sci. 2023 Mar;38(14):e111. https://doi.org/10.3346/jkms.2023.38.e111

31 August 2022 in Clinical and Experimental Reproductive Medicine
Verified
Journal Article
Open access
PDF file
HJHYE GYEONG JEONG
HYE GYEONG JEONG
SKSeul Ki Kim
Seul Ki Kim
JLJung Ryeol Lee
Jung Ryeol Lee
BJByung Chul Jee
Byung Chul Jee
Objective: The aim of this study was to assess the correlation of oocyte number with serum anti-Müllerian hormone (AMH) levels measured by two automated methods (Access or Elecsys) in fresh stimulated in vitro fertilization (IVF) cycles.Methods: In this retrospective study at a university hospital, data were collected from 243 fresh stimulated IVF cycles performed from August 2016 to December 2020. The serum AMH level was measured by Access in 120 cycles and by Elecsys in 123 cycles. The cut-off of serum AMH for prediction of poor responders (three or fewer oocytes) or high responders (15 or more oocytes) was calculated by the receiver operating characteristic curve analysis.Results: For the two automated methods, the following equations were derived: total oocyte number=2.378+1.418×(Access-AMH) (r=0.645, p<0.001) and total oocyte number=2.417+2.163×(Elecsys-AMH) (r=0.686, p<0.001). The following combined equation could be derived: (Access-AMH)=0.028+1.525×(Elecsys-AMH). To predict poor responders, the cut-off of Access-AMH was 1.215 ng/mL (area under the curve [AUC], 0.807; 95% confidence interval [CI], 0.730–0.884; p<0.001), and the cut-off of Elecsys-AMH was 1.095 ng/mL (AUC, 0.848; 95% CI, 0.773–0.923; p<0.001). To predict high responders, the cut-off of Access-AMH was 3.450 ng/mL (AUC, 0.922; 95% CI, 0.862–0.981; p<0.001), and the cut-off of Elecsys-AMH was 2.500 ng/mL (AUC, 0.884; 95% CI, 0.778–0.991; p<0.001).Conclusion: Both automated methods for serum AMH measurement showed a good correlation with oocyte number and good performance for predicting poor and high responders in fresh stimulated IVF cycles. The Access method usually yielded higher measured serum AMH levels than the Elecsys method.